Altox

Database / API & reference standards

API & reference standards

Regorafenib

Regorafenib is listed in the API and reference-standard collection under CAS 755037-03-7. Its represented structure has formula C21H15ClF4N4O3 and a calculated molecular weight of 482.82 g/mol.

2D chemical structure

N H O O N H O N H C l F F F F N

Chemical identity

Catalog name
Regorafenib
Common name
Regorafenib
Chemical name
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
CAS
755037-03-7
SMILES
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1
InChI
InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)
InChIKey
FNHKPVJBJVTLMP-UHFFFAOYSA-N
Associated API
Regorafenib

Record ID: Aba7317c8ea25

Computed properties

C21H15ClF4N4O3 Molecular formula
482.821 g/molMolecular weight
482.0769 DaMonoisotopic exact mass
92.35 ŲTopological polar surface area
5.6888 Calculated LogP (Wildman–Crippen)
113.1966 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
3 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl F H N O 0 5 10 15 20 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight482.82183.33
Calculated LogP (Wildman–Crippen)5.688893.57
Topological polar surface area92.3567.01
Hydrogen-bond acceptors450.68
Hydrogen-bond donors381.39
Rotatable bonds (strict)560.59

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC21H15ClF4N4O3dimensionless
Molecular weight482.821g/mol
Monoisotopic exact mass482.0769Da
Topological polar surface area92.35Ų
Calculated LogP (Wildman–Crippen)5.6888dimensionless
Molar refractivity (Wildman–Crippen)113.1966cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors3count
Rotatable bonds (strict)5count
Heavy atoms33count
Heteroatoms12count
Rings3count
Aromatic rings3count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles1count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.0952fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area189.2766Ų
Valence electrons172count
Radical electrons0count
Bertz complexity1,204.3676index
Balaban J1.684index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Regorafenib

PDE, HBEL and impurity assessment for Regorafenib

For a substance-specific assessment, request a PDE report for Regorafenib or explore HBEL derivation for Regorafenib. These services address exposure limits using toxicological evidence and the intended use of the substance.

For pharmaceutical development, explore prediction of degradation products of Regorafenib and qualification of impurities related to Regorafenib.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Regorafenib

Explore Altox services and software through the Altox Pharma-Hub.